Medications

Promacta approval expanded to kids with rare blood disorder

(HealthDay)—U.S. Food and Drug Administration approval of the drug Promacta (eltrombopag) has been expanded to include children one year and older with a rare blood disorder called chronic immune thrombocytopenic purpura ...

Medical research

Intestinal barrier damage in multiple sclerosis

The present study investigates whether the function of the intestines is also attacked in MS. The results, obtained from a disease model of MS in mice, shows inflammation and changes in the barrier function of the intestines ...

HIV & AIDS

Sexually transmitted HIV: Key mechanisms elucidated in men

Having suggested in 2011 that the urethra is a novel entry site for HIV, a team from the Institut Cochin (CNRS/Inserm/Université Paris Descartes, with the support of Anrs), has now confirmed this hypothesis and identified ...

page 5 from 6